Castle Biosciences (CSTL) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Property, Plant & Equipment (Net) Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 11.62% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | 9.72% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | -0.87% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 9.78% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 2.05% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 49.28% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -2.49% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 1.78% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 4.67% |
| 10 | Castle Biosciences | 917.75 Mn | 650.93 Mn | 79.85 Mn | 41.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.35% |
| Mar 31, 2026 | 82.12% |
| Dec 31, 2025 | 90.61% |
| Sep 30, 2025 | 91.26% |
| Jun 30, 2025 | 91.68% |
| Mar 31, 2025 | 68.44% |
| Dec 31, 2024 | 101.01% |
| Sep 30, 2024 | 99.27% |
| Jun 30, 2024 | 88.38% |
| Mar 31, 2024 | 80.26% |
| Dec 31, 2023 | 77.67% |
| Sep 30, 2023 | 70.62% |
| Jun 30, 2023 | 83.08% |
| Mar 31, 2023 | 94.50% |
| Dec 31, 2022 | 50.67% |
| Sep 30, 2022 | 47.24% |
| Jun 30, 2022 | 38.45% |
| Mar 31, 2022 | 20.63% |
| Dec 31, 2021 | 33.78% |
| Sep 30, 2021 | 33.40% |